[Delineation of organs at risk and dose constraints]

G Noël; D Antoni; I Barillot; B Chauvet

doi:10.1016/j.canrad.2016.07.032

[Delineation of organs at risk and dose constraints]

Cancer Radiother. 2016 Sep:20 Suppl:S36-60. doi: 10.1016/j.canrad.2016.07.032. Epub 2016 Aug 8.

[Article in French]

Authors

G Noël¹, D Antoni², I Barillot³, B Chauvet⁴

Affiliations

¹ Département universitaire de radiothérapie, centre de lutte contre le cancer Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, 67065 Strasbourg, France. Electronic address: [email protected].
² Département universitaire de radiothérapie, centre de lutte contre le cancer Paul-Strauss, 3, rue de la Porte-de-l'Hôpital, 67065 Strasbourg, France.
³ Centre universitaire de cancérologie Henry-S.-Kaplan, CHU, 37044 Tours cedex 9, France.
⁴ Département de radiothérapie, institut Sainte-Catherine, 84918 Avignon cedex 9, France.

PMID: 27516050
DOI: 10.1016/j.canrad.2016.07.032

Abstract

From a review of literature, the objective of this paper is to define limits for delineation of organs at risk and dose constraints in this latter when radiotherapy is delivered with conventional fractionation or with hypofractionation as for stereotactic body radiation therapy.

Keywords: Delineation; Dose; Délinéation; Organes à risque; Organs at risk; Radiotherapy; Radiothérapie; Stereotactic radiation therapy; Stéréotaxie.

Publication types

Practice Guideline
Review

MeSH terms

Dose Fractionation, Radiation
Humans
Models, Theoretical
Neoplasms / radiotherapy
Organ Specificity
Organs at Risk*
Radiation Dose Hypofractionation
Radiation Injuries / prevention & control
Radiation Tolerance
Radiosurgery / adverse effects
Radiosurgery / methods
Radiosurgery / standards
Radiotherapy / adverse effects
Radiotherapy / methods*
Radiotherapy / standards
Radiotherapy Dosage*
Radiotherapy Planning, Computer-Assisted